Literature DB >> 10596385

Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates.

P Horn1, E Münch, P Vajkoczy, P Herrmann, M Quintel, L Schilling, P Schmiedek, L Schürer.   

Abstract

Critically elevated intracranial pressure (ICP) represents the most important cause of morbidity and mortality in patients suffering from severe traumatic brain injury (TBI) and is a serious complication after subarachnoid hemorrhage (SAH). Thus new strategies for the control of ICP are required. Based on the evidence available hypertonic saline solution (HSS) may be a promising approach. It was therefore the aim of the present study to evaluate in a prospective manner the effects of HSS on ICP and cerebral perfusion pressure (CPP) in patients with therapy-resistant elevation of ICP. A total of 48 bolus infusions of HSS (7.5%, 2 ml kg-1 b.w.; infusion rate 20 ml min-1) were given intravenously (range 1-15 per patient) to 10 patients (age 41 +/- 6 years) with TBI and SAH. Only patients with ICP > 25 mmHg not responding to standard ICP-management protocol and plasma sodium (Na+) concentration < 150 mmol l-1 were included in the study. Within the first hour after HSS application, ICP decreased from 33 +/- 9 mmHg to 19 +/- 6 mmHg (p < 0.05) and further to 18 +/- 5 mmHg at the time of maximum effect (98 +/- 11 min post bolus). Decrease of ICP was accompanied by a rise of CPP from 68 +/- 11 mmHg to 79 +/- 11 mmHg (p < 0.05) after 1 h and further to 81 +/- 11 mmHg at the time of maximum effect. Plasma Na+ concentration was 141 +/- 6 mmol l-1 before and 143 +/- 5 mmol l-1 1 h after HSS bolus. Corresponding values for plasma osmolality were 302 +/- 11 and 308 +/- 12 mOsm l-1. When the ICP lowering effect was transient, subsequent HSS bolus was necessary 163 +/- 54 min after previous dosing. The present results indicate that repeated bolus application of HSS (7.5% NaCl, 2 ml kg-1 b.w.) is an effective measure to decrease ICP which is otherwise refractory to standard therapeutic approaches. Whether or not the therapy scheme is also suited as primary measure for the control of ICP remains to be established.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596385     DOI: 10.1080/01616412.1999.11741010

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  26 in total

1.  Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial.

Authors:  Eileen M Bulger; Susanne May; Karen J Brasel; Martin Schreiber; Jeffrey D Kerby; Samuel A Tisherman; Craig Newgard; Arthur Slutsky; Raul Coimbra; Scott Emerson; Joseph P Minei; Berit Bardarson; Peter Kudenchuk; Andrew Baker; Jim Christenson; Ahamed Idris; Daniel Davis; Timothy C Fabian; Tom P Aufderheide; Clifton Callaway; Carolyn Williams; Jane Banek; Christian Vaillancourt; Rardi van Heest; George Sopko; J Steven Hata; David B Hoyt
Journal:  JAMA       Date:  2010-10-06       Impact factor: 56.272

Review 2.  Hypertonic saline for cerebral edema.

Authors:  Alexandros L Georgiadis; José I Suarez
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

Review 3.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities.

Authors:  Eduardo Paredes-Andrade; Craig A Solid; Sarah B Rockswold; Rick M Odland; Gaylan L Rockswold
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 5.  Osmotherapy in neurocritical care.

Authors:  Anish Bhardwaj
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

6.  Hypertonicity promotes survival of corticospinal motoneurons via mitogen-activated protein kinase p38 signaling.

Authors:  Heidi Junger; David B Edelman; Wolfgang G Junger
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

7.  The effects of hypertonic saline and nicotinamide on sensorimotor and cognitive function following cortical contusion injury in the rat.

Authors:  Andrea Quigley; Arlene A Tan; Michael R Hoane
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

8.  Role of hypertonic saline and mannitol in the management of raised intracranial pressure in children: A randomized comparative study.

Authors:  Piyush Upadhyay; V N Tripathi; R P Singh; D Sachan
Journal:  J Pediatr Neurosci       Date:  2010-01

9.  Evaluation of mannitol as an osmotherapeutic agent in traumatic brain injuries by measuring serum osmolality.

Authors:  R M Sharma; R Setlur; M N Swamy
Journal:  Med J Armed Forces India       Date:  2011-08-07

10.  The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury.

Authors:  Umberto Maggiore; Edoardo Picetti; Elio Antonucci; Elisabetta Parenti; Giuseppe Regolisti; Mario Mergoni; Antonella Vezzani; Aderville Cabassi; Enrico Fiaccadori
Journal:  Crit Care       Date:  2009-07-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.